Literature DB >> 12743606

The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex.

Steven E Lang1, Patrick Hearing.   

Abstract

The adenovirus E1A oncoprotein stimulates cell growth and inhibits differentiation by deregulating the normal transcription program via interaction with positive and negative cellular effectors. E1A associates with transcriptional regulatory complexes containing p400 and TRRAP involved in chromatin remodeling and decondensation. TRRAP is a component of three distinct human histone acetyltransferase (HAT) complexes: the TIP60 complex and complexes containing GCN5 or PCAF. We demonstrate here that E1A binds a TRRAP complex that contains the GCN5 acetyltransferase during a normal adenovirus infection. E1A binds GCN5 and TRRAP in vivo early after virus infection. E1A is associated with significant HAT activity in vitro that is partly attributable to GCN5. E1A represses c-Myc- and E2F-1-directed transcriptional activation in vivo by sequestering GCN5 and/or TRRAP. Our results demonstrate that E1A distinctly binds TRRAP/GCN5, p300/CBP and PCAF HAT complexes. Through interactions with multiple HAT complexes, E1A may deregulate cellular transcription programs and facilitate infection by recruiting functional HAT coactivators to viral and cellular promoter regions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743606     DOI: 10.1038/sj.onc.1206376

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A.

Authors:  Jeffrey S Johnson; Yvonne N Osheim; Yuming Xue; Margaux R Emanuel; Peter W Lewis; Alex Bankovich; Ann L Beyer; Daniel A Engel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.

Authors:  Jailal N G Ablack; Michael Cohen; Gobi Thillainadesan; Gregory J Fonseca; Peter Pelka; Joe Torchia; Joe S Mymryk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

5.  E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase.

Authors:  Jingfeng Sha; Mrinal K Ghosh; Keman Zhang; Marian L Harter
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Inhibition of transcriptional activation and cell proliferation activities of adenovirus E1A by the unique N-terminal domain of CtBP2.

Authors:  L-J Zhao; T Subramanian; G Chinnadurai
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

7.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

8.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Viral manipulation of the host epigenome for oncogenic transformation.

Authors:  Roberto Ferrari; Arnold J Berk; Siavash K Kurdistani
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

10.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.